In summary, a buyer today should look for a partner who can meet design demands, maintain international safety certifications (CE, FDA), support OEM/ODM customisation, handle sports-application lenses ...
In Gov. Gavin Newsom’s final State of the State address to the California Legislature, he highlights accomplishments, looks ...
Zacks.com on MSN
The Zacks Analyst Blog Eli Lilly, Medtronic, Intuitive Surgical, Regeneron Pharmaceuticals and Johnson & Johnson
Eli Lilly boasts a wide range of products that serve a vast number of therapeutic areas. LLY focuses primarily on cardiometabolic health, neuroscience, oncology and immunology, which are all ...
Under the terms of the agreement, Iktos will leverage its AI-driven generative design platform to accelerate the discovery of optimized small-molecule candidates against an undisclosed oncology target ...
Heron Therapeutics, Inc. (Nasdaq: HRTX) ('Heron” or the 'Company”), a commercial-stage biotechnology company, today announced ...
Philstar.com on MSN
Drug war critic priest targeted by coordinated smear campaign
Dozens of social media accounts deployed identical messages, suspicious comment patterns and AI-generated content to attack a ...
The phrases "best electrolyte supplement" and "top hydration packets" are used in this report to reflect common consumer search behavior in 2026. This analysis does not rank products, verify outcomes, ...
New name to reflect recent transformative acquisition of rights to Phase 3 program in metastatic breast cancer and commitment to continued leadership, resilience and innovation ...
News-Medical.Net on MSN
Making food labels easier to read didn’t stop unhealthy eating
A UK study reveals that food label readability initially reduced sandwich consumption, but effects faded over time, ...
Medications once used to treat illness are increasingly being taken for prevention. Experts explain what’s behind the ...
By using a patient's DNA to craft personalized drug treatments, doctors can increase the efficacy and better the outcomes of ...
Just in time for the holidays, on December 15, 2025, the U.S. Food and Drug Administration (“FDA”) Office of Prescription Drug Promotion (“OPDP”) issued an untitled letter (the “Letter”) to Karuna ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results